{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:03:06Z","timestamp":1793037786586,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG073338"],"award-info":[{"award-number":["R01AG073338"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM122059"],"award-info":[{"award-number":["R01GM122059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0903"],"award-info":[{"award-number":["W81XWH-22-1-0903"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","award":["R01GM122059"],"award-info":[{"award-number":["R01GM122059"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","award":["R01AG073338"],"award-info":[{"award-number":["R01AG073338"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbadis.2023.166769","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:39:09Z","timestamp":1685493549000},"page":"166769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger"],"prefix":"10.1016","volume":"1869","author":[{"given":"Nick","family":"Schoenmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tannenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Hodgeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavan Pillai","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0026-0495(70)90119-8","article-title":"Diisopropylammonium dichloroacetate (DIPA) and sodium dichloracetate (DCA): effect on glucose and fat metabolism in normal and diabetic tissue","volume":"19","author":"Stacpoole","year":"1970","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166769_bb0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197803092981002","article-title":"Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia","volume":"298","author":"Stacpoole","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166769_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4093\/dmj.2013.37.5.301","article-title":"Regulation of muscle pyruvate dehydrogenase complex in insulin resistance: effects of exercise and dichloroacetate","volume":"37","author":"Constantin-Teodosiu","year":"2013","journal-title":"Diabetes Metab. J."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj1340651","article-title":"Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (short communication)","volume":"134","author":"Whitehouse","year":"1973","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166769_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/bs.irn.2019.05.003","article-title":"Dichloroacetate-induced peripheral neuropathy","volume":"145","author":"Stacpoole","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbadis.2023.166769_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cbi.2014.02.015","article-title":"Chloride and other anions inhibit dichloroacetate-induced inactivation of human liver GSTZ1 in a haplotype-dependent manner","volume":"215","author":"Zhong","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2023.166769_bb0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pharmthera.2016.10.018","article-title":"Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1","volume":"170","author":"James","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166769_bb0040","doi-asserted-by":"crossref","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","article-title":"The pyruvate dehydrogenase complexes: structure-based function and regulation","volume":"289","author":"Patel","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188568","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166769_bb0050","doi-asserted-by":"crossref","first-page":"E855","DOI":"10.1152\/ajpendo.00526.2002","article-title":"Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs","volume":"284","author":"Sugden","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166769_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/HP.S99044","article-title":"Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells","volume":"4","author":"Zimmer","year":"2016","journal-title":"Hypoxia (Auckl.)"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166769_bb0060","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204402","article-title":"Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166769_bb0065","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1542\/peds.2007-2062","article-title":"Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate","volume":"121","author":"Stacpoole","year":"2008","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.bbadis.2023.166769_bb0070","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/MCB.22.13.4943-4951.2002","article-title":"Maleylacetoacetate isomerase (MAAI\/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism","volume":"22","author":"Fernandez-Canon","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"Suppl. 4","key":"10.1016\/j.bbadis.2023.166769_bb0075","first-page":"989","article-title":"Clinical pharmacology and toxicology of dichloroacetate","volume":"106","author":"Stacpoole","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166769_bb0080","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bbadis.2012.03.004","article-title":"Primary hyperoxalurias: disorders of glyoxylate detoxification","volume":"1822","author":"Salido","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166769_bb0085","doi-asserted-by":"crossref","first-page":"C1359","DOI":"10.1152\/ajpcell.00238.2004","article-title":"Glycolate and glyoxylate metabolism in HepG2 cells","volume":"287","author":"Baker","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jcp.27.7.558","article-title":"Thiamine deficiency and oxalosis","volume":"27","author":"Salyer","year":"1974","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0272-0590(90)90212-3","article-title":"Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats","volume":"14","author":"Stacpoole","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0317167100026020","article-title":"Peripheral neuropathy in oxalosis. A case report with electron microscopic observations","volume":"3","author":"Bilbao","year":"1976","journal-title":"Can. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mus.24495","article-title":"Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria","volume":"51","author":"Berini","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2023.166769_bb0110","series-title":"Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A clinician\u2019s Approach","author":"Darras","year":"2015"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1289\/ehp.1002554","article-title":"The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine\u2014both or neither?","volume":"119","author":"Stacpoole","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166769_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/tx990175q","article-title":"Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate","volume":"13","author":"Tzeng","year":"2000","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.107.134593","article-title":"Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity","volume":"324","author":"Shroads","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166769_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.526","article-title":"GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial","volume":"7","author":"Tian","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00008571-200002000-00007","article-title":"Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis","volume":"10","author":"Blackburn","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0140","first-page":"683","article-title":"Efficacy of dichloroacetate as a lactate-lowering drug","volume":"43","author":"Stacpoole","year":"2003","journal-title":"J. Clin. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2023.166769_bb0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2004.06.009","article-title":"Chronic treatment of mitochondrial disease patients with dichloroacetate","volume":"83","author":"Barshop","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"22","key":"10.1016\/j.bbadis.2023.166769_bb0150","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199211263272204","article-title":"A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group","volume":"327","author":"Stacpoole","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166769_bb0155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1542\/peds.2005-1226","article-title":"Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children","volume":"117","author":"Stacpoole","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM198308183090702","article-title":"Treatment of lactic acidosis with dichloroacetate","volume":"309","author":"Stacpoole","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj1460447","article-title":"Metabolic interactions of dichloroacetate and insulin in experimental diabetic ketoacidosis","volume":"146","author":"Backshear","year":"1975","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166769_bb0170","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diacare.15.6.785","article-title":"Dichloroacetate","volume":"15","author":"Stacpoole","year":"1992","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08889","article-title":"Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis","volume":"8","author":"Katayama","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/diab.23.3.179","article-title":"Treatment of streptozotocin diabetes with di-isopropylammonium dichloroacetate (DIPA)","volume":"23","author":"Eichner","year":"1974","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166769_bb0185","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2337\/db14-1560","article-title":"Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: a combined 13C hyperpolarized magnetic resonance and echocardiography study","volume":"64","author":"Le Page","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0190","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.109.888479","article-title":"Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure","volume":"3","author":"Kato","year":"2010","journal-title":"Circ. Heart Fail"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/toxsci\/kfy272","article-title":"Dichloroacetate ameliorates cardiac dysfunction caused by ischemic insults through AMPK signal pathway-not only shifts metabolism","volume":"167","author":"Li","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SHK.0000000000000730","article-title":"The AMPK activator Aicar ameliorates age-dependent myocardial injury in murine hemorrhagic shock","volume":"47","author":"Matsiukevich","year":"2017","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.bbadis.2023.166769_bb0205","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1111\/jog.15045","article-title":"Protective effects of dichloroacetic acid on endometrial injury and ovarian reserve in an experimental rat model of diabetes mellitus","volume":"47","author":"Pala","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166769_bb0210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know?","volume":"100","author":"Nagy","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","article-title":"Vascular endothelial growth factor signaling in hypoxia and inflammation","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166769_bb0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","article-title":"VEGF-A and the induction of pathological angiogenesis","volume":"2","author":"Nagy","year":"2007","journal-title":"Annu. Rev. Pathol."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166769_bb0225","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1158\/0008-5472.CAN-04-2345","article-title":"Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis","volume":"65","author":"Bjorndahl","year":"2005","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.bbadis.2023.166769_bb0230","doi-asserted-by":"crossref","first-page":"31ra34","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166769_bb0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"51","key":"10.1016\/j.bbadis.2023.166769_bb0245","doi-asserted-by":"crossref","first-page":"25389","DOI":"10.1073\/pnas.1916144116","article-title":"Repurposing dichloroacetate for the treatment of women with endometriosis","volume":"116","author":"Horne","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0250","first-page":"617","article-title":"Dichloroacetate and cancer: new home for an orphan drug?","volume":"1846","author":"Kankotia","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166769_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis in cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"7546","key":"10.1016\/j.bbadis.2023.166769_bb0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12885-021-09151-2","article-title":"Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions","volume":"22","author":"Rostamian","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41388-019-1035-8","article-title":"Dichloroacetate restores colorectal cancer chemosensitivity through the p53\/miR-149-3p\/PDK2-mediated glucose metabolic pathway","volume":"39","author":"Liang","year":"2020","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.bbadis.2023.166769_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212553","article-title":"Impact of sodium dichloroacetate alone and in combination therapies on lung tumor growth and metastasis","volume":"22","author":"Al-Azawi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166769_bb0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-4598-10-142","article-title":"Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells","volume":"10","author":"Sun","year":"2011","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-009-0435-9","article-title":"Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo","volume":"120","author":"Sun","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166769_bb0290","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1681\/ASN.2015070827","article-title":"Dichloroacetate prevents cisplatin-induced nephrotoxicity without compromising cisplatin anticancer properties","volume":"27","author":"Galgamuwa","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166769_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249367","article-title":"Dichloroacetate radiosensitizes hypoxic breast cancer cells","volume":"21","author":"de Mey","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bbadis.2023.166769_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147265","article-title":"Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas","volume":"22","author":"Cook","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0305","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10863-012-9496-2","article-title":"Case report: sodium dichloroacetate (DCA) inhibition of the \u201cWarburg effect\u201d in a human cancer patient: complete response in non-Hodgkin\u2019s lymphoma after disease progression with rituximab-CHOP","volume":"45","author":"Strum","year":"2013","journal-title":"J. Bioenerg. Biomembr."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0310","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10637-022-01235-5","article-title":"Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma","volume":"40","author":"Powell","year":"2022","journal-title":"Investig. New Drugs"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0315","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0320","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1165\/rcmb.2016-0186OC","article-title":"Targeting hypoxia-inducible factor-1alpha\/pyruvate dehydrogenase kinase 1 Axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis","volume":"58","author":"Goodwin","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0325","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acsabm.0c00443","article-title":"Binary prodrug of dichloroacetic acid and doxorubicin with enhanced anticancer activity","volume":"4","author":"Sharma","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166769_bb0330","first-page":"6573","article-title":"Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1alpha\/SIRT3 signaling and suppression of oxidative stress and apoptosis","volume":"25","author":"Saleh","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166769_bb0335","first-page":"1","article-title":"Deaths: injuries, 2002","volume":"54","author":"Minino","year":"2006","journal-title":"Natl. Vital Stat. Rep."},{"issue":"6 Suppl 1","key":"10.1016\/j.bbadis.2023.166769_bb0340","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/TA.0000000000000641","article-title":"Massive transfusion policies at trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program","volume":"78","author":"Camazine","year":"2015","journal-title":"J. Trauma Acute Care Surg."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/SHK.0000000000001676","article-title":"Complications of hemorrhagic shock and massive transfusion-a comparison before and after the damage control resuscitation era","volume":"56","author":"Black","year":"2021","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166769_bb0350","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMra1705649","article-title":"Hemorrhagic shock","volume":"378","author":"Cannon","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0355","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0039-3402426","article-title":"The evolution of blood transfusion in the trauma patient: whole blood has come full circle","volume":"46","author":"Black","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166769_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135032","article-title":"Inhaled carbon monoxide protects against the development of shock and mitochondrial injury following hemorrhage and resuscitation","volume":"10","author":"Gomez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166769_bb0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuropharm.2015.07.033","article-title":"Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model","volume":"99","author":"Rao","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2023.166769_bb0370","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fmed.2019.00281","article-title":"A combination treatment strategy for hemorrhagic shock in a rat model modulates autophagy","volume":"6","author":"Chu","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0375","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/SHK.0b013e3181cffe7d","article-title":"Hypoxia-induced alteration of mitochondrial genes in cardiomyocytes: role of Bnip3 and Pdk1","volume":"34","author":"Jian","year":"2010","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0390","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-017-02495-5","article-title":"Mitochondrial targeting by dichloroacetate improves outcome following hemorrhagic shock","volume":"7","author":"Subramani","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2119\/molmed.2015.00013","article-title":"Resveratrol improves survival and prolongs life following hemorrhagic shock","volume":"21","author":"Ayub","year":"2015","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166769_bb0400","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1006\/jmcc.1997.0483","article-title":"Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock","volume":"29","author":"Kline","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0405","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00024382-200014020-00022","article-title":"Depletion of lactate by dichloroacetate reduces cardiac efficiency after hemorrhagic shock","volume":"14","author":"Barbee","year":"2000","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166769_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241122","article-title":"Dichloroacetate-induced metabolic reprogramming improves lifespan in a Drosophila model of surviving sepsis","volume":"15","author":"Bakalov","year":"2020","journal-title":"PLoS One"},{"issue":"7519","key":"10.1016\/j.bbadis.2023.166769_bb0415","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1378\/chest.15-1703","article-title":"Lactic acidosis in sepsis: it\u2019s not all anaerobic: implications for diagnosis and management","volume":"149","author":"Suetrong","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.bbadis.2023.166769_bb0425","series-title":"Lactic Acidosis","author":"Foucher","year":"2022"},{"issue":"15","key":"10.1016\/j.bbadis.2023.166769_bb0430","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99292","article-title":"Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival","volume":"3","author":"McCall","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.bbadis.2023.166769_bb0435","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153944","article-title":"Dichloroacetate improves systemic energy balance and feeding behavior during sepsis","volume":"7","author":"Oh","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2023.166769_bb0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64611","article-title":"Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction","volume":"10","author":"Mainali","year":"2021","journal-title":"Elife"},{"issue":"195","key":"10.1016\/j.bbadis.2023.166769_bb0445","doi-asserted-by":"crossref","first-page":"195ra95","DOI":"10.1126\/scitranslmed.3005893","article-title":"An integrated clinico-metabolomic model improves prediction of death in sepsis","volume":"5","author":"Langley","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166769_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.783164","article-title":"The pyruvate dehydrogenase complex in sepsis: metabolic regulation and targeted therapy","volume":"8","author":"Zeng","year":"2021","journal-title":"Front. Nutr."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0455","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2394-8108.186256","article-title":"Pyruvate dehydrogenase complex in cerebral ischemia-reperfusion injury","volume":"2","author":"Thibodeau","year":"2016","journal-title":"Brain Circ."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2023.166769_bb0460","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(97)00833-0","article-title":"Reduced activity of the pyruvate dehydrogenase complex but not cytochrome c oxidase is associated with neuronal loss in the striatum following short-term forebrain ischemia","volume":"772","author":"Zaidan","year":"1997","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0465","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/STROKEAHA.114.006994","article-title":"Ethanol and normobaric oxygen: novel approach in modulating pyruvate dehydrogenase complex after severe transient and permanent ischemic stroke","volume":"46","author":"Geng","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2023.166769_bb0470","doi-asserted-by":"crossref","first-page":"5173035","DOI":"10.1155\/2021\/5173035","article-title":"DCA protects against oxidation injury attributed to cerebral ischemia-reperfusion by regulating glycolysis through PDK2-PDH-Nrf2 Axis","volume":"2021","author":"Zhao","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02736749","article-title":"Dichloroacetate attenuates neuronal damage in a gerbil model of brain ischemia","volume":"5","author":"Dimlich","year":"1994","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166769_bb0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(96)12542-8","article-title":"Protective effect of dichloroacetate in a rat model of forebrain ischemia","volume":"208","author":"Peeling","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2023.166769_bb0485","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fneur.2018.00137","article-title":"Combined treatment with dichloroacetic acid and pyruvate reduces hippocampal neuronal death after transient cerebral ischemia","volume":"9","author":"Hong","year":"2018","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166769_bb0490","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/WNL.55.9.1376","article-title":"MR spectroscopy study of dichloroacetate treatment after ischemic stroke","volume":"55","author":"Graham","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166769_bb0495","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ana.21511","article-title":"Glucose and NADPH oxidase drive neuronal superoxide formation in stroke","volume":"64","author":"Suh","year":"2008","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0500","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/pgs-2015-0012","article-title":"Pharmacogenetic considerations with dichloroacetate dosing","volume":"17","author":"James","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0505","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Investig. New Drugs"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166769_bb0510","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10637-015-0221-y","article-title":"A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Investig. New Drugs"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0515","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mus.1089","article-title":"Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetate","volume":"24","author":"Spruijt","year":"2001","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166769_bb0520","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019","article-title":"Long-term safety of dichloroacetate in congenital lactic acidosis","volume":"109","author":"Abdelmalak","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"413","key":"10.1016\/j.bbadis.2023.166769_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4583","article-title":"Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients","volume":"9","author":"Michelakis","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166769_bb0530","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.braindev.2003.12.009","article-title":"Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS","volume":"26","author":"Mori","year":"2004","journal-title":"Brain and Development"},{"key":"10.1016\/j.bbadis.2023.166769_bb0535","series-title":"Pharmacotoxicology of Trichloroethylene Metabolites","author":"Stacpoole","year":"2014"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:51:50Z","timestamp":1782481910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0925443923001357"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166769","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166769"}}